| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Otolaryngology/Head and Neck Surgery, University Hospital Vrije Universiteit, 1007 MB Amsterdam [R. H. B., J. G. W. S., C. t. B., R. d. B., G. B. S., G. A. M. S. v. D.]; and In Vitro Fertilisation Laboratory, University Hospital Utrecht, 3508 GA Utrecht [S. M. W.], the Netherlands
In previous studies, we described the selective reactivity of monoclonal antibody E48 with normal squamous and transitional epithelia and their malignant counterparts and the capacity of monoclonal antibody E48 for selective tumor targeting in head and neck cancer patients. Cloning of the E48 encoding cDNA and elucidation of the gene structure enabled the selection of an intron-spanning primer set for the detection of circulating tumor cells in blood and bone marrow of head and neck cancer patients. Extensive optimizations led to a reproducible reverse transcriptase-PCR assay with an internal standard for RNA quality control and an external standard for sensitivity control. In reconstruction experiments, we were able to reach a reproducible sensitivity of one single tumor cell per 7 ml of blood (2 x 107 nucleated cells). When applying this method to patient material, we were able to detect positive signal in 35% of the bone marrow samples (0 of 2 stage II, 0 of 4 stage III, 4 of 11 stage IV, and 4 of 6 recurrences) and 10% of the blood samples (2 of 21) of patients with squamous cell carcinoma of the head and neck. The specificity of the method was demonstrated on 29 blood and bone marrow samples of noncancer controls, which were all negative. Our study shows the feasibility of E48 reverse transcriptase-PCR for the detection of squamous cells in nonsquamous tissues.
This article has been cited by other articles:
|
|
 |
|
  P. Blancafort, E. I. Chen, B. Gonzalez, S. Bergquist, A. Zijlstra, D. Guthy, A. Brachat, R. H. Brakenhoff, J. P. Quigley, D. Erdmann, et al. Genetic reprogramming of tumor cells by zinc finger transcription factors PNAS, August 16, 2005; 102(33): 11716 - 11721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Colnot, E. J. C. Nieuwenhuis, D. J. Kuik, C. R. Leemans, J. Dijkstra, G. B. Snow, G. A. M. S. van Dongen, and R. H. Brakenhoff Clinical Significance of Micrometastatic Cells Detected by E48 (Ly-6D) Reverse Transcription-Polymerase Chain Reaction in Bone Marrow of Head and Neck Cancer Patients Clin. Cancer Res., December 1, 2004; 10(23): 7827 - 7833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Partridge, R. Brakenhoff, E. Phillips, K. Ali, R. Francis, R. Hooper, K. Lavery, A. Brown, and J. Langdon Detection of Rare Disseminated Tumor Cells Identifies Head and Neck Cancer Patients at Risk of Treatment Failure Clin. Cancer Res., November 1, 2003; 9(14): 5287 - 5294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. C. Nieuwenhuis, L. H. Jaspars, J. A. Castelijns, B. Bakker, R. G. A. Wishaupt, F. Denkers, C. R. Leemans, G. B. Snow, and R. H. Brakenhoff Quantitative Molecular Detection of Minimal Residual Head and Neck Cancer in Lymph Node Aspirates Clin. Cancer Res., February 1, 2003; 9(2): 755 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Myers and B. R. Gastman Neck Dissection: An Operation in Evolution: Hayes Martin Lecture Arch Otolaryngol Head Neck Surg, January 1, 2003; 129(1): 14 - 25. [Full Text] [PDF]
|
|
|
|
 |
|
 F A Vlems, J H S Diepstra, I M H A Cornelissen, T J M Ruers, M J L Ligtenberg, C J A Punt, J H J M van Krieken, T. Wobbes, and G N P van Muijen Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue Mol. Pathol., June 1, 2002; 55(3): 156 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. M. van Houten, M. P. Tabor, M. W. M. van den Brekel, F. Denkers, R. G. A. Wishaupt, J. A. Kummer, G. B. Snow, and R. H. Brakenhoff Molecular Assays for the Diagnosis of Minimal Residual Head-and-Neck Cancer: Methods, Reliability, Pitfalls, and Solutions Clin. Cancer Res., October 1, 2000; 6(10): 3803 - 3816. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Pantel, R. J. Cote, and O. Fodstad Detection and Clinical Importance of Micrometastatic Disease J Natl Cancer Inst, July 7, 1999; 91(13): 1113 - 1124. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
